Last reviewed · How we verify
28 days treatment with Mifepristone. — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
28 days treatment with Mifepristone. (28 days treatment with Mifepristone.) — Stanford University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 28 days treatment with Mifepristone. TARGET | 28 days treatment with Mifepristone. | Stanford University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 28 days treatment with Mifepristone. CI watch — RSS
- 28 days treatment with Mifepristone. CI watch — Atom
- 28 days treatment with Mifepristone. CI watch — JSON
- 28 days treatment with Mifepristone. alone — RSS
Cite this brief
Drug Landscape (2026). 28 days treatment with Mifepristone. — Competitive Intelligence Brief. https://druglandscape.com/ci/28-days-treatment-with-mifepristone. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab